恶性疟原虫膜蛋白Pfs25在毕赤酵母中的组成型表达

目的:Pfs25蛋白是传播阻断型恶性疟疾疫苗的侯选抗原,在毕赤酵母中表达Pfs25蛋白,并对表达产物进行鉴定。方法:参照GenBank中公布的pfs25基因序列,通过毕赤酵母喜好密码子分析人工合成目的基因;采取定向克隆策略构建重组表达质粒pfs25/pGAPZαA,经BstXⅠ线性化,电转染法转化酵母菌株GS115,在Zeocin抗性的筛选培养基上获得表达目的基因的pfs25/pGAPZαA/GS115重组酵母菌,SDS-PAGE和Western印迹检测表达产物;通过在YPD培养基上传代培养和目的基因表达,验证重组菌株的遗传稳定性。结果:在毕赤酵母中表达了Pfs25蛋白,且重组菌株遗传性质稳定。结论:为研制基于Pfs25蛋白的传播阻断型恶性疟疾疫苗奠定了基础。     

传播阻断型疟疾疫苗的研究进展

由于抗药疟原虫和蚊虫的出现,给疟疾防治带来了困难。研发安全有效的疟疾疫苗是当前全球疟疾防治的迫切需求。目前,正在研究的疟疾疫苗主要包括红前期疟疾疫苗、红内期疟疾疫苗和传播阻断型疟疾疫苗。其中传播阻断型疫苗(Transmission-blocking vaccines,TBVs)被认为是一种在疟疾流行地区降低病原体传播的可行策略。近年来,传播阻断型疟疾疫苗的研制取得了很大的进展。本文综述了传播阻断型疟疾疫苗的用途、靶抗原以及传播阻断型恶性疟疾和间日疟疾疫苗研究现状,旨在为传播阻断型疟疾疫苗的研制提供参考。     

恶性疟原虫pfs25多拷贝基因在毕赤酵母中的表达分析

目的:对恶性疟原虫pfs25的多拷贝基因重组菌株在毕赤酵母中进行表达分析,研究基因拷贝数对Pfs25蛋白表达量的影响。方法:构建重组质粒pAO815-αpfs25,利用BglⅡ-BamHⅠ同尾酶的特点,将基因表达框AOX1-αpfs25-AOX1(TT)插入到单拷贝表达质粒,依次重复,构建多拷贝重组质粒pAO815-(αpfs25)n,线性化后电转化毕赤酵母GS115,用MD平板筛选并进行表达分析。结果:构建得到1、2、3、4、5、6、7、8、10、12和14个pfs25基因拷贝的重组菌株,8拷贝pfs25基因的重组菌株表达量最高。结论:成功得到了pfs25基因的多拷贝表达重组菌株,经分析,多拷贝pfs25基因的目的蛋白表达量与其拷贝数并不呈线性正相关。     

传播阻断性恶性疟疾疫苗研发:进展、挑战及前景

<正>为降低疟疾的发病率和致死率,需要对疟疾采取新的治疗手段,同时应加快消除疟疾和最终消灭疟疾的步伐。为实现消灭疟疾这个目标,旨在打破寄生虫传播循环、防止疟疾复发的治疗手段至关重要。因此,传播阻断型恶性疟疾疫苗被视作重要的疟疾治疗手段,包括阻断人蚊传播的传播阻断型疟疾疫苗(VIMT),该疫苗针对的是寄生虫的有性生殖和孢子生殖阶段,或者说是蚊子体内阶段(SSM-VIMT)。在过去的几年中,当疟疾研究领域开始着手于     

菌体表面表达与活菌疫苗

展示表达是将目的蛋白基因与细胞表面结构蛋白融合,使目的蛋白表达并锚定于细胞表面的一项技术,微生物特别是细菌常用作展示表达的宿主。在大肠杆菌中,多种外膜蛋白、鞭毛蛋白、菌毛蛋白、脂蛋白等均已被用于表达和锚定外源蛋白,革兰氏阴性菌中,较明确的是蛋白Ａ可用以细胞表面的整合,Ｍ６蛋白也被尝试用于乳酸菌的展示表达,酵母表达体系中,将目的蛋白与凝集素融合可表达细胞表面,菌体表面表达的蛋白容易被免疫系统识别,能引起强烈的免疫反应。其中沙门菌、大肠杆菌、链球菌等展示表达的致病细菌或病毒的抗原和毒素用于免疫动物均能产生高滴度的中和抗体,用作疫苗大有前途。本文对表达体系和在疫苗方面的应用进行了概述     

禽流感病毒HA基因真核表达质粒的构建与表达

血凝素蛋白（HA）基因是禽流感病毒（AIV）重要的保护性抗原基因.为了研究 HA基因疫苗,用PCR扩增H5亚型AIV HA基因,将其克隆到质粒pcDNA4/HisMax和pRc/CMV上得到真核表达质粒pC4H5和pCMVH5.采用Tfx^TM-20、Superfect转染试剂和电转染法转染HeLa细胞,转染后的HeLa细胞经蛋白质印迹和血凝试验检测HA蛋白及其活性.结果表明,Superfect转染和电转染均能正确表达HA蛋白并具有生物学活性,蛋白质印迹检测到HA和HA裂解的HA1和HA2,与AIV 的HA、HA1、HA2蛋白的分子质量一致.从血凝试验结果看,Superfect和电转染表达的HA均具有血凝活性,而经Superfect转染的pC4H5的表达量是pCMVH5的8倍,表明pC4H5是一高效的真核表达质粒.     

新型疟疾传播阻断疫苗候选抗原PbPSOP7基因截短片段的克隆及表达特点的研究

传播阻断疫苗(transmission-blocking vaccines,TBVs)可以有效地阻断疟原虫从蚊媒向人的传播,是控制疟疾流行的关键,但目前的TBVs候选抗原十分有限,迫切需要寻找有效的候选抗原。动合子分泌蛋白7(putative secreted ookinete protein 7,PSOP7)在疟原虫有性生殖阶段发挥着至关重要的作用,本研究对伯氏疟原虫抗原PSOP7(Pb PSOP7)进行简要的生物信息学分析,并应用原核表达系统高效表达纯化了截短的重组Pb PSOP7蛋白(r Pb PSOP7),免疫BALB/c小鼠后,获得小鼠高滴度多克隆抗体。经Western Blot方法证实该多克隆抗体可识别疟原虫抗原。间接免疫荧光实验显示,Pb PSOP7主要表达于疟原虫的合子与动合子表面。这些特点符合TBVs的基本设计理念,为确认和证实Pb PSOP7蛋白具有疟疾TBVs候选抗原的潜能奠定基础。     

微生物介导的疟原虫Pfs25和Pvs25疫苗研制现状

恶性疟原虫和间日疟原虫可分别引起恶性疟和间日疟。采用疫苗防治疟疾是当前研究的热点领域之一。Pfs25和Pvs25抗原是2种疟疾传播阻断期的疫苗候选分子,本文简要综述了根癌农杆菌、酵母菌、腺病毒、牛痘病毒和杆状病毒等微生物介导的疟原虫Pfs25和Pvs25疫苗的研制现状。     

体外培养恶性滋养细胞P53蛋白表达与细胞生物学特性的研究

本文对23例恶性滋养细胞和19例正常早孕绒毛滋养细胞进行了原代培养。分别采用免疫组化、反转录PCR、放免法和酶联免疫吸附法,检测了体外培养滋养细胞P53蛋白和β-hCGmRNA的表达、β-hCG、hPL和IL-6含量的变化。体外培养的恶性滋养细胞中,细胞滋养细胞增生异常活跃,细胞核呈明显异型。恶性滋养细胞P53蛋白阳性表达,且阳性强度与正常早孕绒毛滋养细胞比较均有显著差异(P<0．01)。体外分泌β-hCG和IL-6的含量均显著高于正常滋养细胞(P<0．05)。P53蛋白的表达以及IL-6的分泌可能与恶性滋养细胞的异常增殖和低分化有关。     

猪瘟病毒E2基因在昆虫细胞/杆状病毒中的表达

目的利用昆虫细胞/杆状病毒系统表达猪瘟病毒(CSFV)E2蛋白,用于E2蛋白功能、开发CSF新型疫苗以及建立相关血清学诊断方法等研究。方法采用RT-PCR扩增CSFV E2基因,将PCR产物克隆到pGEM-T-Easy载体,将该基因插入到pFast-BacHT A载体中,构建重组转座载体后转化DH10Bac感受态细胞,获得重组Bacmid质粒后转染sf9昆虫细胞,传毒3代,对表达蛋白进行Western-blot及免疫组化鉴定。结果成功克隆CSFVE2基因,其核苷酸序列为1119 bp。SDS-PAGE电泳结果显示表达E2蛋白相对分子质量约为43×103,Western-blot和免疫组化结果证实表达蛋白能够被CSFV标准阳性血清识别。结论在Bac-to-Bac杆状病毒系统中的成功表达了CSFV E2蛋白,与CSFV标准阳性血清具有较好的反应性。     

Tumor-specific gene expression patterns with gene expression profiles

Gene expression profiles of 14 common tumors and their counterpart normal tissues were analyzed with machine learning methods to address the problem of selection of tumor-specific genes and analysis of their differential expressions in tumor tissues. First, a variation of the Relief algorithm, “RFE_Relief algorithm” was proposed to learn the relations between genes and tissue types. Then, a support vector machine was employed to find the gene subset with the best classification performance for distinguishing cancerous tissues and their counterparts. After tissue-specific genes were removed, cross validation experiments were employed to demonstrate the common deregulated expressions of the selected gene in tumor tissues. The results indicate the existence of a specific expression fingerprint of these genes that is shared in different tumor tissues, and the hallmarks of the expression patterns of these genes in cancerous tissues are summarized at the end of this paper.     

Tumor-specific gene expression patterns with gene expression profiles

Gene expression profiles of 14 common tumors and their counterpart normal tissues were analyzed with machine learning methods to address the problem of selection of tumor-specific genes and analysis of their differential expressions in tumor tissues. First, a variation of the Relief algorithm, "RFE_Relief algorithm" was proposed to learn the relations between genes and tissue types. Then, a support vector machine was employed to find the gene subset with the best classification performance for distinguishing cancerous tissues and their counterparts. After tissue-specific genes were removed, cross validation experiments were employed to demonstrate the common deregulated expressions of the selected gene in tumor tissues. The results indicate the existence of a specific expression fingerprint of these genes that is shared in different tumor tissues, and the hallmarks of the expression patterns of these genes in cancerous tissues are summarized at the end of this paper.     

High-level expression of full-length antibodies using trans-complementing expression vectors

Recombinant antibodies are increasingly used as therapeutics for a wide variety of diseases. Generation of cell lines expressing high levels of recombinant antibody typically requires labor-intensive cloning and screening steps. We describe a mammalian expression system for the high-level production of full-length antibody molecules. It has been shown that the dihydrofolate reductase (DHFR) selectable marker can be divided into two fragments that, with the aid of a leucine zipper, can re-associate to form an active molecule. Using bicistronic vectors, we linked the expression of each antibody chain to the expression of a DHFR fragment. Survival in selective media requires expression of both DHFR fragments that, by virtue of these vectors, also selects for the expression of both antibody chains. Initial pools produced 5 microg of Ab/10(6) cells/d (qP = microg/10(6) cells/d). Expression of each antibody chain in conjunction with a portion of DHFR also leads to concurrent amplification of both antibody chains in the presence of methotrexate, a DHFR inhibitor, and results in a two- to fivefold increase in antibody production with basal qPs ranging from 10-25 ug/10(6) cells/d. Shake-flask cultures of amplified pools produced up to 600 mg/L of antibody in 7 days. This system allows for rapid generation of antibodies without cloning and greatly simplifies selection of cell lines for the production of potential antibody therapeutics.     

Auxin-regulated gene expression

During the 1960s a wide range of studies provided an information base that led to the suggestion that auxin-regulated cell processes--especially cell elongation--may be mediated by auxin-regulated gene expression. Indirect evidence from our work, based on the influence of inhibitors of RNA synthesis (e.g. actinomycin D) and of protein synthesis (e.g. cycloheximide) on auxin-induced cell elongation, coupled with correlations of the influence of auxin on RNA synthesis and cell elongation, provided the basis for this suggestion. With the availability of techniques for DNA-DNA and DNA-RNA hybridization, mRNA isolation-translation, in vitro 2D gel analysis of the translation products, and ultimately the cloning by recombinant DNA technologies of genomic DNA and copy DNAs (cDNAs) made to poly(A)+ mRNAs, we and others have provided direct evidence for the influence of auxin on the expression of a few genes (i.e. poly(A)+ RNA levels). Our laboratory has provided evidence for auxin's both down-regulating and up-regulating the level of a few poly(A)+ mRNAs out of a population of about 4 X 10(4) sequences that are not significantly affected by auxin. In our studies on auxin-regulated cell elongation, two cDNA clones (pJCW1 and pJCW2) were isolated which corresponded to poly(A)+ mRNAs that responded during growth transitions in a way consistent with a potential role of their protein products in cell elongation. These mRNAs are most abundant in the elongating zone of the soybean hypocotyl. Upon excision and incubation in the absence of auxin, these mRNAs deplete in concert with a decreasing rate of cell elongation. Addition of auxin to the medium results in both increased levels of these mRNAs and enhanced rates of cell elongation. These mRNAs do not deplete if auxin is added to the medium at the onset of excised incubation, and cell elongation rates remain high. We have isolated and sequenced genomic clones that are homologous to these cDNAs. Of the two genes sequenced, both genes are members of small multigene families. There are regions of high amino acid homology even though the nucleotide sequences are sufficiently different in these regions for cross-hybridization of the clones not to be observed. More recently others, especially Guilfoyle's laboratory, have shown that auxin selectively and rapidly influences the level of certain mRNAs and proteins. We have worked on other gene systems such as ribosomal proteins and possible cell wall proteins that are responsive to auxin; again the nature of regulation of expression of these genes is not known.(ABSTRACT TRUNCATED AT 400 WORDS)